India Identified Market Barriers for Chinese Trade

Indian exporters face access hurdles for key goods, driving reliance on third-country transit routes.

Updated on Sept. 26, 2026 in Economic Policy

Isometric editorial illustration of a stack of shipping containers on a dock, representing complex international trade routes.
Finance Minister Nirmala Sitharaman reported that structural trade barriers force Indian exporters to transit high-value goods through Vietnam to reach Chinese markets. AI Illustration. Upload story photo >

Live Poll

Should the government prioritize domestic manufacturing to reduce dependence on foreign trade?

Finance Minister Nirmala Sitharaman highlighted structural barriers preventing direct trade of Indian goods into China. These restrictions force high-value exports, including buffalo meat and pharmaceuticals, to reach Chinese markets via transit through Vietnam.

Why it matters

The denial of direct market access complicates supply chain logistics and costs for Indian producers competing in China. These trade barriers, coupled with previous losses in API production due to predatory pricing, underpin India's push to bolster domestic manufacturing.

80% of state tax revenue is currently absorbed by committed expenditures, leaving just 20% available for capital investments. Meanwhile, some states continue to borrow beyond the established 3% GSDP ceiling.

The players

Nirmala Sitharaman

As the Finance Minister of India, she directs national fiscal policy and oversees industrial incentive programs.

India

A major emerging economy and manufacturing hub focused on reducing import dependencies and expanding industrial capacity.

China

A dominant global manufacturing and trade power that currently enforces market access restrictions on specific Indian-made goods.

The details

Indian producers utilize Vietnam as a logistics hub to bypass restricted access to Chinese markets for goods such as buffalo meat and generic pharmaceuticals. To mitigate reliance on these complex supply chains, the Indian government is deploying fiscal incentives to shift production of active pharmaceutical ingredients (APIs) back to domestic facilities. This strategy aims to reverse the competitive disadvantage caused by historical predatory pricing practices that eroded India's leadership in chemical and drug manufacturing.

Timeline

  1. Finance Minister Nirmala Sitharaman discussed trade barriers on September 25, 2026.

Market Landscape

India's trade strategy sits against a backdrop of fiscal pressure, with states frequently testing the 3 percent GSDP borrowing ceiling while managing limited capital budgets. This policy environment mirrors broader efforts to reduce import reliance through state-backed industrial incentives.

Operators in the pharmaceutical and export sectors should evaluate their dependency on transit-heavy supply chains and monitor for incoming domestic production incentives. Firms should also track fiscal compliance trends in states where they operate, particularly concerning the 3% borrowing threshold.

The takeaway

Businesses must account for non-tariff trade barriers as a permanent factor in their cross-border logistics strategy. Operators should actively monitor government budget announcements for new industrial incentives that could lower the cost of domestic sourcing.

Further reading

For more on how government trade initiatives influence manufacturing, see Economic Policy.

Live Poll

Should the government prioritize domestic manufacturing to reduce dependence on foreign trade?